Filter By Unselect All

Sub Category Unselect

Country Unselect

Companies Unselect See All

Selected Filter(s): Reset All

  • Category
  • Reset
  • Sub Category
  • Reset
  • Country
  • Reset

Contact

Narcotics & High Potency Drugs

Packaging >> Contract Services >> High Potent / Biologic / Controlled Substance

CIT is one of the most established and respected independent Contract Packagers in Europe. The strategic position of the plant and the proven innovative knowledge in packaging and logistic processes make CIT an ideal hub to Europe.

Contact

High Containment Packaging

Packaging >> Contract Services >> High Potent / Biologic / Controlled Substance

Millmount Healthcare’s high containment facility is specifically designed for the packaging of high potency pharmaceutical compounds with both blister packaging and bottle / tub filling services available.

Contact

Controlled Substance Packaging of Solid Dosage

Packaging >> Contract Services >> High Potent / Biologic / Controlled Substance

All Aphena’s facilities are DEA licensed to handle class CII-CV controlled substances. All controlled substances are secured, handled and stored in accordance with DEA regulations.

Contact

Secondary Packaging - Potents, Controlled Substances

Packaging >> Contract Services >> High Potent / Biologic / Controlled Substance

Precision labeling technologies support parenteral applications including vials and ampoules, syringes and injectable devices, as well as transdermals and eye care applications.

Packaging of controlled substances or biologics or high potent substances requires a license by Drug Enforcement Agency (“DEA”). As a contract Development and Manufacturing Organization (CDMO), pharmaceutical packaging companies offer a full range of integrated services, technology and support for the development, manufacturing and packaging of solid dose and non-sterile liquid pharmaceuticals. Contract packaging services of high potent or biologics or controlled substance provides customized and innovative clinical packaging materials. With GMP compliant clinical packaging facilities they offer Clinical packaging of high potent or biologics or controlled substance with Bottling (solids / semi-solids), Blister packaging – any configuration, Cold form & thermoform, Blister card sealing and walleting, Pouching / powder filling, Label application and kit assembly, Controlled substance packaging (schedule I – V), Ambient & controlled temperature (refrigerated / frozen) packaging, Tube filling, Creams, Ointments, Label printing with vision system.(Single panel,Multipanel booklet labels). Packaging design of high potent or biologics or controlled substance from simple pack design to complex, unique packaging requirements companies designing and engineering team can advise and guide clients on the optimal configuration. Their solutions offer practical approaches to support everything from complex temperature requirements to packaging and label options that are designed with the patient and site in mind. Whether clients need the labeling and assembly of prefilled syringes, device blinding for inhalers and vials, or advice on the packaging and distribution of controlled substances, packaging companies can provide guidance on a full range of your packaging requirements. Packaging equipment for high potent or biologics or controlled substance needed for today’s pharma/biopharma products continue to be very flexible and modular systems to handle very specific needs. Also, working with equipment providers to achieve this has become part of the drug production process for pharma/biopharma. Packaging materials for high potent or biologics or controlled substance one of the fastest-growing segments of the pharmaceutical market comprises formulated drugs based on highly potent active pharmaceutical ingredients (HPAPIs). This rapid growth is largely attributed to the growing number of antibody-drug conjugates (ADCs) that have recently been approved or are in development. These drugs are attractive because they are targeted therapies that deliver highly potent and often cytotoxic drugs (payloads) to selective sites in the body, linking them to antibodies that are taken up by only specific types of cells with the right antigens. Because the active drug is only released at the site of action, ADCs can be delivered systemically without causing harm to healthy cells.

ABOUT
THE PAGE

COLLAPSE